Hormone therapy for the management of the menopause in Ecuador: Perception, use and knowledge among middle-aged women

References

• Castelo-Branco C, Rostro F. Management of menopause. Minerva Ginecol 2006; 58: 137–152
   PubMedGoogle Scholar
• Castelo-Branco C, Palacios S, Calaf J, Vazquez F, Lanchares J L. Available medical choices for the management of menopause. Maturitas 2005; 52(Suppl 1)S61–S70
   PubMedGoogle Scholar
• Castelo-Branco C, Cancelo M J, Villero J, Nohales F, Julia M D. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005; 52(Suppl 1)S46–S52
   PubMed Web of Science ®Google Scholar
• Blumel J E, Castelo-Branco C, Leal T, Gallardo L, Saini J, Ferron S, Haya J. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease. Climacteric 2003; 6: 38–44
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Vicente J J, Figueras F, Sanjuan A, Martinez de Osaba M J, Casals E, Pons F, Balasch J, Vanrell J A. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000; 34: 161–168
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Duran M, Puig M, Vanrell J A. Compliance with hormone replacement therapy at the menopause. J Obstet Gynaecol 1995; 15: 204–205
   Google Scholar
• Castelo-Branco C, Figueras F, Sanjuan A, Vicente J J, Martinez de Osaba M J, Pons F, Balasch J, Vanrell J A. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999; 6: 307–311
   PubMed Web of Science ®Google Scholar
• Blumel J E, Castelo-Branco C, Riquelme R, Araya H, Jaramillo P, Tacla X, Colodrón M, Lavín P. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002; 9: 377–380
   PubMed Web of Science ®Google Scholar
• Bianco V, Murina F, Roberti P, Valente I. Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience. Minerva Ginecol 2006; 58: 335–344
   PubMedGoogle Scholar
• Castelo-Branco C, Peralta S, Ferrer J, Palacios S, Cornago S, Quereda F. The dilemma of menopause and hormone replacement – a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women. Climacteric 2006; 9: 380–387
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 2007; 56: 420–428
   PubMed Web of Science ®Google Scholar
• Hara Y, Shintani M. [Compliance of hormone replacement therapy in postmenopausal women in Japan]. Nippon Rinsho 2004; 62(Suppl 2)496–500
   Google Scholar
• Ferguson K J, Hoegh C, Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med 1989; 149: 133–136
   PubMed Web of Science ®Google Scholar
• Corrado F, D'Anna R, Caputo F, Cannata M L, Zoccali M G, Cancellieri F. Compliance with hormone replacement therapy in postmenopausal Sicilian women. Eur J Obstet Gynecol Reprod Biol 2005; 118: 225–228
   PubMed Web of Science ®Google Scholar
• Wattanakumtornkul S, Chichareon S, Geater A, Suwan K. Compliance with hormone replacement therapy at Songklanagarind Hospital. J Obstet Gynaecol Res 2003; 29: 380–387
   PubMed Web of Science ®Google Scholar
• Yasui T, Uemura H, Takikawa M, Irahara M. Hormone replacement therapy in postmenopausal women. J Med Invest 2003; 50: 136–145
   PubMedGoogle Scholar
• Shmuely Y, Berlin J A, Knauss J, Lydick E. Compliance with oral HRT in postmenopausal women in clinical trials – meta analysis. Maturitas 2003; 46: 33–44
   PubMed Web of Science ®Google Scholar
• Lindh-Astrand L, Brynhildsen J, Hoffmann M, Liffner S, Hammar M. Attitudes towards the menopause and hormone therapy over the turn of the century. Maturitas 2007; 56: 12–20
   PubMedGoogle Scholar
• Ekstrom H. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it. Maturitas 2005; 52: 154–164
   PubMed Web of Science ®Google Scholar
• Blumel J E, Castelo-Branco C, Chedraui P A, Binfa L, Dowlani B, Gomez M S, Sarra S. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004; 11: 57–61
   PubMed Web of Science ®Google Scholar
• Lazar F, Jr., Costa-Paiva L, Morais S S, Pedro A O, Pinto-Neto A M. The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women's Health Initiative study. Maturitas 2007; 56: 129–141
   PubMed Web of Science ®Google Scholar
• Travers C, O'Neill S M, Khoo S K, King R. Hormones down under: hormone therapy use after the Women's Health Initiative. Aust N Z J Obstet Gynaecol 2006; 46: 330–335
   PubMed Web of Science ®Google Scholar
• Gerend M A, Aiken L S, Erchull M J, Lapin A. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change. Prev Med 2006; 43: 158–164
   PubMed Web of Science ®Google Scholar
• Power M L, Zinberg S, Schulkin J. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy. Menopause 2006; 13: 434–441
   PubMed Web of Science ®Google Scholar
• Kang B M, Kim M R, Park H M, Yoon B K, Lee B S, Chung H W, Cho S H, Choi H, Kim J G. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study. Menopause 2006; 13: 125–129
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Hammar M, Kjellgren K I, Lindh-Astrand L, Brynhildsen J. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005; 52: 11–17
   PubMed Web of Science ®Google Scholar
• Longworth J C. Hispanic women's experience with ‘el cambio de vida’. J Am Acad Nurs Pract 2003; 15: 266–275
   PubMedGoogle Scholar
• Castelo-Branco C, Blumel J E, Chedraui P, Calle A, Bocanera R, Depiano E, Figueroa-Casas P, Gonzalez C, Martino M, Royer M, et al. Age at menopause in Latin America. Menopause 2006; 13: 706–712
   PubMed Web of Science ®Google Scholar
• Leon P, Chedraui P, Hidalgo L, Ortiz F. Perceptions and attitudes toward the menopause among middle aged women from Guayaquil, Ecuador. Maturitas 2007; 57: 233–238
   PubMed Web of Science ®Google Scholar
• Hvas L. Menopausal women's positive experience of growing older. Maturitas 2006; 54: 245–251
   PubMed Web of Science ®Google Scholar
• Kowalcek I, Rotte D, Banz C, Diedrich K. Women's attitude and perceptions towards menopause in different cultures. Cross-cultural and intra-cultural comparison of pre-menopausal and post-menopausal women in Germany and in Papua New Guinea. Maturitas 2005; 51: 227–235
   PubMed Web of Science ®Google Scholar
• Melby M K, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update 2005; 11: 495–512
   PubMed Web of Science ®Google Scholar
• Lock M. Symptom reporting at menopause: a review of cross-cultural findings. J Br Menopause Soc 2002; 8: 132–136
   PubMedGoogle Scholar
• Gavin N I, Thorp J M, Ohsfeldt R L. Determinants of hormone replacement therapy duration among postmenopausal women with intact uteri. Menopause 2001; 8: 377–383
   PubMed Web of Science ®Google Scholar
• Sturdee D W. The importance of patient education in improving compliance. Climacteric 2000; 3(Suppl 2)9–13
   PubMedGoogle Scholar
• Eiken P, Kolthoff N. Compliance with 10 years oral hormonal replacement therapy. Maturitas 2002; 41: 81–86
   PubMedGoogle Scholar
• Beral V, Banks E, Reeves G, Appleby P. Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat 1999; 4: 191–210
   PubMedGoogle Scholar
• Armstrong K, Popik S, Guerra C, Ubel P A. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Med Decis Making 2000; 20: 308–313
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Ferrer J, Palacios S, Cornago S. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists. Maturitas 2006; 55: 308–316
   PubMed Web of Science ®Google Scholar
• Carney P A, Tosteson A N, Titus-Ernstoff L, Weiss J E, Goodrich M E, Manganiello P, Kasales C J. Hormone therapies in women aged 40 and older: prevalence and correlates of use. Maturitas 2006; 53: 65–76
   PubMedGoogle Scholar
• Olesen A V, Johnsen S P, Mortensen J T, Boggild H, Olsen J, Sorensen H T. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Gynecol Scand 2005; 84: 639–644
   PubMed Web of Science ®Google Scholar
• Donker G A, Spreeuwenberg P, Bartelds A I, van der Velden K, Foets M. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium. Fam Pract 2000; 17: 508–513
   PubMedGoogle Scholar
• Jolleys J V, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996; 23: 47–53
   PubMed Web of Science ®Google Scholar
• Bermejo M J, Perez I R. Physicians and the prescription of hormone replacement therapy in Spain. Health Policy 2005; 73: 58–65
   PubMed Web of Science ®Google Scholar
• Roberson N L. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 1994; 74: 2687–2691
   PubMed Web of Science ®Google Scholar
• Safran D G, Taira D A, Rogers W H, Kosinski M, Ware J E, Tarlov A R. Linking primary care performance to outcomes of care. J Fam Pract 1998; 47: 213–220
   PubMed Web of Science ®Google Scholar